Erector Spinae Plane Block Versus Classic Epidural Analgesia in Labor
NCT ID: NCT04776512
Last Updated: 2021-03-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
50 participants
INTERVENTIONAL
2021-03-01
2021-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
At the sencond stage of labor: 3cm of cervix dilatation, patients will be randomized in 2 groups:
* ESP group: patients will receive ultrasound guided, bilateral ESP Block performed at the level of the 3 rd Lumbar transverse process.
* Epidural Analgesia Group: Patients will have a classic lumbar continuous epidural analgesia.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study Comparing Dural Puncture Epidural With Epidural and Combined Spinal Epidural Anesthesia for Obstetric Analgesia.
NCT05196256
Dural Puncture Epidural VS Standard Epidural on Physician Top-ups During Labour Analgesia
NCT04728048
Comparison of Epidural Labor Pain Relief Techniques on Maternal and Fetal Outcomes
NCT02008591
Compared Efficacy of Patient-controlled Epidural Analgesia With or Without Automatic Boluses
NCT03407209
Spinal Analgesia as Fast Track Painless Labor
NCT05271760
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
At the sencond stage of labor: 3cm of cervix dilatation, patients will be randomized in 2 groups:
* ESP group: patients will receive ultrasound guided, bilateral ESP Block performed at the level of the 3 rd Lumbar transverse process.
* Epidural Analgesia Group: Patients will have a classic lumbar continuous epidural analgesia.
For the first group: 20 ml of 0,375% isobaric Bupivacain solution will be injected bilaterally under ultrasound direct vision.
Concerning the second group, patients will have a continuous injection of 0,125% Bupivacain solution associated to 0,25 mcg of Sufentanil/ml through an epidural catheter in the L3-L4 or L4-L5 intervertebral space.
For the 2 groups, analgesia will be assessed during all the labor period hourly using the Visual Analog pain Score (VAS).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Epidural Analgesia
Patients of this group Will receive an epidural analgesia through a lumbar epidural catheter
Epidural Analgesia
Continuous Lumbar Epidural analgesia With 0,125% Bupivacain+0,25 mcg/ml Sufentanil
ESP Block
Bilateral ESP block performed at the level of the 3 rd Lumbar transverse process.
ESP Block With Bupivacain
bilateral lumbar ESP block using 0.375% Bupivacain
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ESP Block With Bupivacain
bilateral lumbar ESP block using 0.375% Bupivacain
Epidural Analgesia
Continuous Lumbar Epidural analgesia With 0,125% Bupivacain+0,25 mcg/ml Sufentanil
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* singleton pregnancy
* No contraindications to perimedullar analgesia techniques
Exclusion Criteria
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mongi Slim Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mhamed Sami Mebazaa
Professor head of anesthesia and intensive care department
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ESP versus Epidural analgesia
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.